Effect of total hip arthroplasty on improving locomotive syndrome in hip disease patients: A prospective cohort study focused on total clinical decision limits stage 3

• Published in: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association Vol. 27; no. 2; pp. 408 - 413
• Main Authors: Miyazaki, Shigeaki, Tsuruta, Kurumi, Yoshinaga, Saori, Yamaguchi, Yoichiro, Fujii, Yoshinori, Arakawa, Hideki, Ochiai, Masaru, Kawaguchi, Tsubasa, Unoki, Aya, Sakamoto, Takero, Tajima, Takuya, Nakamura, Yoshihiro, Funamoto, Taro, Hiyoshi, Masaru, Chosa, Etsuo
• Format: Journal Article
• Language: English
• Published: Japan Elsevier B.V 01.03.2022
• Subjects: Aged; Arthroplasty, Replacement, Hip; Exercise Test; Humans; Locomotion; Prospective Studies; Syndrome
• ISSN: 0949-2658; 1436-2023
• DOI: 10.1016/j.jos.2020.12.028

In 2020, the Japanese Orthopaedic Association established a new stage 3 in clinical decision limits (CDL) to evaluate the stage of locomotive syndrome (LS). This study focused on total CDL stage 3 with the aim of investigating indicators related to improvements in total CDL by evaluating the improvement of LS in patients who underwent total hip arthroplasty (THA). Of the 125 patients who underwent THA at our hospital, the subjects of the analysis were 105 patients determined to be total CDL stage 3 in an evaluation performed before THA. LS was evaluated using the stand-up test, two-step test, and 25-Question Geriatric Locomotive Function Scale (GLFS-25). Indicators related to improvements in total CDL were also investigated. All evaluation items were measured before THA and three months after THA. Before THA, all subjects (n = 105) were classified as total CDL stage 3. Three months after THA, improvements in total CDL were seen in 49 subjects (46.7%). The results of stepwise multiple logistic regression analysis showed that the before THA stand-up test and GLFS-25 were significantly related to improvements in total CDL. Three months after THA, improvements in LS were seen in approximately half of the subjects. The stand-up test and GLFS-25 can be used as indicators of improvement in total CDL. Prospective cohort study design.